Geode Capital Management, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Geode Capital Management, LLC

$1.12 Trillion
Q2 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$144.95 - $152.29 $3.66 Million - $3.84 Million	25,237 Added 2.35%	1,097,362 $166 Million
Q2 2022 Aug 12, 2022	BUY	$83.14 - $145.99 $5.61 Million - $9.86 Million	67,512 Added 6.72%	1,072,125 $156 Million
Q1 2022 May 13, 2022	BUY	$110.08 - $142.92 $4.79 Million - $6.22 Million	43,523 Added 4.53%	1,004,613 $119 Million
Q4 2021 Feb 11, 2022	BUY	$99.73 - $148.48 $2.21 Million - $3.28 Million	22,116 Added 2.36%	961,090 $132 Million
Q3 2021 Nov 12, 2021	BUY	$98.85 - $138.91 $2.52 Million - $3.55 Million	25,524 Added 2.79%	938,974 $130 Million
Q2 2021 Aug 13, 2021	BUY	$65.78 - $105.02 $6.37 Million - $10.2 Million	96,911 Added 11.87%	913,450 $88.7 Million
Q1 2021 May 12, 2021	BUY	$64.07 - $91.75 $5.12 Million - $7.33 Million	79,943 Added 10.85%	816,539 $55.8 Million
Q4 2020 Feb 12, 2021	BUY	$65.07 - $98.24 $2.86 Million - $4.31 Million	43,886 Added 6.34%	736,596 $63.1 Million
Q3 2020 Nov 13, 2020	BUY	$59.04 - $77.95 $2.14 Million - $2.82 Million	36,174 Added 5.51%	692,710 $45 Million
Q2 2020 Aug 13, 2020	BUY	$29.01 - $74.23 $1.45 Million - $3.7 Million	49,845 Added 8.22%	656,536 $48 Million
Q1 2020 May 14, 2020	BUY	$27.51 - $57.29 $2.44 Million - $5.09 Million	88,876 Added 17.16%	606,691 $20.6 Million
Q4 2019 Feb 13, 2020	BUY	$40.86 - $57.65 $7,967 - $11,241	195 Added 0.04%	517,815 $28.2 Million
Q3 2019 Nov 12, 2019	BUY	$37.38 - $49.47 $1.63 Million - $2.15 Million	43,520 Added 9.18%	517,620 $21.6 Million
Q2 2019 Aug 14, 2019	BUY	$39.79 - $67.01 $3.2 Million - $5.4 Million	80,514 Added 20.46%	474,100 $20.8 Million
Q1 2019 May 14, 2019	BUY	$34.52 - $53.29 $1.38 Million - $2.13 Million	39,939 Added 11.29%	393,586 $20.3 Million
Q4 2018 Feb 13, 2019	BUY	$29.75 - $42.9 $2.47 Million - $3.56 Million	82,960 Added 30.65%	353,647 $13.1 Million
Q3 2018 Nov 13, 2018	BUY	$32.79 - $43.0 $577,923 - $757,875	17,625 Added 6.96%	270,687 $10.2 Million
Q2 2018 Aug 14, 2018	BUY	$23.62 - $42.29 $1.79 Million - $3.2 Million	75,604 Added 42.6%	253,062 $10 Million
Q1 2018 May 15, 2018	BUY	$22.49 - $34.56 $120,321 - $184,896	5,350 Added 3.11%	177,458 $4.57 Million
Q4 2017 Feb 13, 2018	BUY	$20.44 - $35.56 $427,359 - $743,488	20,908 Added 13.83%	172,108 $4.64 Million
Q3 2017 Nov 14, 2017	SELL	$23.54 - $38.21 $322,592 - $523,629	-13,704 Reduced 8.31%	151,200 $5.65 Million
Q2 2017 Aug 14, 2017	BUY	N/A	164,904	164,904 $4.12 Million

Others Institutions Holding BHVN

# of Institutions

Shares Held

785K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account